Login to Your Account

MDCO's Rempex buy validated with Vabomere approval

By Marie Powers
News Editor

Wednesday, August 30, 2017

The Medicines Co. moved Vabomere across the goal line, garnering FDA approval to treat adults with complicated urinary tract infections, including pyelonephritis, caused by designated susceptible Enterobacteriaceae – Escherichia coli, Klebsiella pneumoniae and Enterobacter cloacae species complex.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription